CDK4 and cancer: Table 3 shows that there is no significance between the levels of CDK4 (quantified as FPKM expression) and the patient’s age, time since diagnosis or status (p = 0.308; 0.768; 0.114 respectively). However, significance was found between the expression of FPKM and the cancer stage (p = 0.031).